CRIS Current Research Information System

PAROLIN, CAROLA ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.631
EU - Europa 5.265
AS - Asia 1.804
AF - Africa 331
SA - Sud America 20
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.065
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.606
IT - Italia 1.576
GB - Regno Unito 1.349
VN - Vietnam 688
CN - Cina 626
SE - Svezia 616
DE - Germania 597
IN - India 284
IE - Irlanda 206
UA - Ucraina 206
FR - Francia 196
RU - Federazione Russa 193
TG - Togo 112
ZA - Sudafrica 101
EE - Estonia 66
CI - Costa d'Avorio 49
NG - Nigeria 49
JO - Giordania 48
PK - Pakistan 48
BG - Bulgaria 44
CH - Svizzera 41
BE - Belgio 35
SG - Singapore 27
FI - Finlandia 22
NL - Olanda 21
CA - Canada 18
IR - Iran 18
GR - Grecia 16
HR - Croazia 15
PL - Polonia 13
SC - Seychelles 12
ES - Italia 11
JP - Giappone 11
LB - Libano 11
TR - Turchia 10
RO - Romania 9
BR - Brasile 8
AT - Austria 7
AU - Australia 7
CZ - Repubblica Ceca 6
KR - Corea 6
EG - Egitto 5
NZ - Nuova Zelanda 5
PH - Filippine 5
CL - Cile 4
DK - Danimarca 4
PT - Portogallo 4
UZ - Uzbekistan 4
IQ - Iraq 3
MX - Messico 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
AR - Argentina 2
BZ - Belize 2
DZ - Algeria 2
EC - Ecuador 2
HU - Ungheria 2
IL - Israele 2
MT - Malta 2
MY - Malesia 2
NO - Norvegia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
EU - Europa 1
GL - Groenlandia 1
HK - Hong Kong 1
ID - Indonesia 1
IS - Islanda 1
MA - Marocco 1
MD - Moldavia 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 13.065
Salva come PNG Salva come JPEG
Città #
Southend 1.242
Ashburn 842
Chandler 715
Fairfield 432
Dong Ket 369
Bologna 349
Ann Arbor 335
Princeton 264
Houston 235
Wilmington 234
Seattle 229
Woodbridge 216
Dublin 204
Cambridge 174
Padova 117
Westminster 115
Lomé 112
Nanjing 108
Berlin 96
Jacksonville 90
New York 85
Redmond 84
Medford 78
Beijing 68
Jinan 68
Milan 67
Saint Petersburg 62
Frankfurt am Main 61
Turin 58
Boardman 57
Dearborn 55
Rome 53
Shenyang 52
Abeokuta 49
Abidjan 49
Amman 48
Gujranwala 44
Sofia 44
Hebei 43
Nanchang 43
San Diego 41
Changsha 33
Tukwila 32
Redwood City 31
Brussels 29
Florence 29
San Jose 29
Des Moines 27
Falls Church 27
Tianjin 26
Helsinki 22
Bern 21
Jiaxing 21
Mülheim 20
Bremen 19
Guangzhou 19
Kuban 19
Haikou 18
Naples 18
Norwalk 18
Pune 17
Ningbo 15
Phoenix 15
Singapore 15
Toronto 15
Zhengzhou 14
Forlì 13
Verona 13
Washington 13
Catania 12
Modena 12
Paris 12
Amsterdam 11
Cagliari 11
Hangzhou 11
Mahé 11
Olalla 11
Piacenza 11
Taiyuan 10
Chicago 9
Los Angeles 9
Napoli 9
Andover 8
Bari 8
Fremont 8
Parma 8
Taizhou 8
Tokyo 8
Venezia 8
Bühl 7
Kunming 7
Mountain View 7
Rimini 7
Shanghai 7
Cesena 6
Erlenbach 6
Fuzhou 6
Genoa 6
Lanzhou 6
Leawood 6
Totale 8.541
Salva come PNG Salva come JPEG
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 459
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 401
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 270
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 198
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 187
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study 181
A peptidic hydrogel that may behave as a "trojan Horse" 179
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 178
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 172
Isolation of vaginal lactobacilli and characterization of anti-candida activity 167
null 156
MICROBIOTA VAGINALE IN CORSO DI INFEZIONI DEL TRATTO GENITALE 154
A new EGFR inhibitor induces apoptosis in colon cancer cells. 153
Determination of antibacterial and technological properties of vaginal lactobacilli for their potential application in dairy products 140
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 139
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 134
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 133
ANTITUMOR ACTIVITY OF INDOLE-DERIVATIVES IN THE HUMAN OVARIAN CANCER CELL LINE IGROV-1 130
Bacterial concentration detection using a portable embedded sensor system for environmental monitoring 130
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 130
ANTIPROLIFERATIVE ACTIVITY OF ENANTIOMERICALLY PURE (R) AND (S)-9-HYDROXYSTEARIC ACID IN HT29 COLON CANCER CELLS. 128
Diversity of vaginal microbiome and metabolome during genital infections 127
ANTITUMOR ACTIVITY OF NEW SUBSTITUTED 3-(5- IMIDAZO[2,1-b]THIAZOLYLMETHYLENE)-2-INDOLINONES 126
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 125
9-Hydroxystearic acid interferes with EGF signalling in a human colon adenocarcinoma 124
(R)-9-HSA HAS A MORE REMARKABLE ANTIPROLIFERATIVE EFFECT COMPARE TO (S)-9-HSA. 123
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 123
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 121
A NEW EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR IN COLON CANCER CELLS 121
9-Hydroxystearic acid and sulforaphane: two natural HDAC inhibitors with distinct effects on HT29 cells. 120
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 120
null 119
A NEW EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR IN COLON CANCER CELLS 118
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 118
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 117
In-vitro effect of vaginal lactobacilli against group B Streptococcus 116
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 114
Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis 113
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 112
Development of azithromycin-loaded microemulsions for the treatment of skin infections 110
Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing 108
Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections 108
Vaginal Lactobacillus strains interfere with Chlamydia trachomatis infection 105
Cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 101
BIOLOGICAL EFFECTS OF A NEW CLASS I HDAC SELECTIVE INHIBITOR IN HT29 COLON CANCER CELLS. 100
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 100
Redox Signaling via Lipid Peroxidation Regulates Retinal Progenitor Cell Differentiation. 99
Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity 97
null 96
Myocardial Induction of Nucleostemin in Response to Postnatal Growth and Pathological Challenge 95
Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets 95
Insight into phenotypic and genotypic differences between vaginal Lactobacillus crispatus BC5 and Lactobacillus gasseri BC12 to unravel nutritional and stress factors influencing their metabolic activity 95
VAGINAL MICROBIOME FOR THE PRESERVATION OF WOMEN’S HEALTH USING FOOD STRATEGY 95
null 94
Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells 92
Electrical Impedance Spectroscopy (EIS) characterization of saline solutions with a low-cost portable measurement system 91
Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities 90
CYTOSTATIC AND CYTOTOXIC EFFECTS OF A NEW SYNTHESIZED GUANYLHYDRAZONE DERIVATIVES IN HUMAN LEUKEMIC CELL LINE HL-60 89
Evaluation of the fate of Lactobacillus crispatus BC4, carried in Squacquerone cheese, throughout the simulator of the human intestinal microbial ecosystem (SHIME) 89
Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study. 89
New Spanish Broom dressings based on Vitamin E and Lactobacillus plantarum for superficial skin wounds 88
A portable sensor system for bacterial concentration monitoring in metalworking fluids 87
Characterization of anti-Candida activity of vaginal lactobacilli 86
Heterologous production of five Hepatitis C Virus-derived antigens in three Saccharomyces cerevisiae host strains 85
THE INDOLE-DERIVATIVE 3L INTERFERES WITH ESTROGEN RECEPTOR SIGNALLING IN IGROV 1 OVARIAN CANCER CELLS 84
Synbiotic vaginal insert containing Lactobacillus crispatus, fructo-oligosaccharides and ascorbic acid: technological and microbiological characterization 84
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry 83
Vaginal microbiome signatures in Chlamydia trachomatis infected women 83
CANDIDIASIS, CHLAMYDIA INFECTION, BACTERIAL VAGINOSIS: A BIOINFORMATICS APPROACH FOR PATHOLOGICAL VAGINAL MICROBIOME CHARACTERIZATION 83
NUCLEAR REDISTRIBUTION OF EXOGENOUS ADMINISTERED 9- AND 10-HSA, ANALYZED BY MASS SPECTROMETRY 82
CYTOTOXICITY EVALUATION OF A POLYAMINE-QUINONE LIBRARY CONJUGATES IN HUMAN COLON CARCINOMA CELLS 82
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors 82
Antiproliferative activity of enantiomerically pure (R)-9-hydroxystearic acid in HT29 colon cancer cells. 82
Computer vision approach for the determination of microbial concentration and growth kinetics using a low cost sensor system 82
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 80
Metabolic profiling of Candida clinical isolates of different species and infection sources 80
Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues 80
NUCLEAR REDISTRIBUTION OF EXOGENOUS ADMINISTERED 9- AND 10-HSA, ANALYZED BY MASS SPECTROMETRY 79
Lactobacillus strains isolated from vaginal microbiota of healthy women inhibit Candida growth and adherence 79
Lactobacillus crispatus to produce a functional cheese as dietary strategy to improve woman wellbeing 79
Mucoadhesive Buccal Films for Local Delivery of Lactobacillus brevis 79
Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm 79
HISTONE POST-TRANSLATIONAL MODIFICATIONS BY HPLC-ESI-MS AFTER HT29 CELL TREATMENT WITH HDACS INHIBITORS. 78
Lactobacillus crispatus interferes with Chlamydia trachomatis infectivity through modulation of integrin exposure in cervical cells 78
Genotypic and phenotypic characterization of Lactobacillus strains with antipathogenic activities 78
Peptide mass mapping of acetylated isoforms of histone H4 from HT29 colon cancer cells 77
null 77
Univariate statistical analysis as a guide to1H-NMR spectra signal assignment by visual inspection 77
The Protective Antimicrobial Activity of Vsl#3 Depends on the Manufacturing Sites 77
Formation of large coronary arteries by cardiac progenitor cells 76
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 75
Development and validation of a new phylogenetic DNA-microarray specific for the oral microbiota 75
Interaction of vaginal Lactobacillus strains with HeLa cell plasma membrane. 74
null 73
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 73
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 72
Candidiasis, Chlamydia Infection and Bacterial Vaginosis: a bioinformatic approach for pathological vaginal microbiome characterization 72
Histones post-translational modifications in colon cancer cell line determined by HPLC-ESI-MS and Maldi-Tof for the characterization of deacetylase inhibitors 71
Probiotic and metabolic characterization of vaginal lactobacilli for a potential use in functional foods 71
Dietary fatty acids, intestinal microbiota and cancer 70
Totale 11.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.862
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019209 0 0 0 0 0 0 0 0 0 0 90 119
2019/20202.564 468 106 32 153 213 228 265 326 311 198 129 135
2020/20212.251 380 91 68 93 115 65 56 119 278 130 107 749
2021/20222.631 315 126 149 110 231 154 92 170 103 193 511 477
2022/20233.236 313 461 195 409 237 245 86 176 507 190 222 195
2023/20241.781 107 171 104 140 163 378 210 354 56 96 2 0
Totale 13.563